DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) Director Daniel D. Springer sold 581,588 shares of the firm’s stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $97.04, for a total value of $56,437,299.52. Following the completion of the sale, the director now directly owns 906,430 shares of the company’s stock, valued at $87,959,967.20. The trade was a 39.08 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
DocuSign Stock Down 0.2 %
NASDAQ:DOCU opened at $94.52 on Friday. The firm has a market capitalization of $19.19 billion, a PE ratio of 19.53, a price-to-earnings-growth ratio of 11.08 and a beta of 0.92. The firm has a 50-day moving average price of $76.80 and a 200 day moving average price of $62.86. DocuSign, Inc. has a 12-month low of $48.70 and a 12-month high of $107.86.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in the business. Itau Unibanco Holding S.A. acquired a new stake in shares of DocuSign during the third quarter worth about $28,000. Brooklyn Investment Group bought a new position in shares of DocuSign in the third quarter valued at about $33,000. Reston Wealth Management LLC acquired a new stake in DocuSign during the third quarter worth approximately $47,000. nVerses Capital LLC acquired a new position in DocuSign in the 2nd quarter valued at $48,000. Finally, Wilmington Savings Fund Society FSB bought a new position in DocuSign during the third quarter worth about $51,000. 77.64% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Get Our Latest Stock Analysis on DocuSign
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Further Reading
- Five stocks we like better than DocuSign
- What Are the U.K. Market Holidays? How to Invest and Trade
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- Why Are Stock Sectors Important to Successful Investing?
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.